课题基金 / 基金详情

Regulation of anti-tumor T cell responses by Hippo pathway kinase Mst1

Regulation of anti-tumor T cell responses by Hippo pathway kinase Mst1
Hippo 通路激酶 Mst1 调节抗肿瘤 T 细胞反应
批准号：
458663
负责人：
Bouchard Antoine
金额：
$7.65万
依托单位：
Institut de recherches cliniques de Montral
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458663&lang=en
关键词：
Anti-Tumor T Cell Immunity Cd8 T Stem-Cell Memory (Tscm) Flow Cytometry And Phosphoflow Hippo Signaling Immune Checkpoint Blockade Immunotherapy Melanoma Tumor Transplantation Model Single-Cell Rna Sequencing T Regulatory Cells (Tregs) Wnt Signal

项目摘要

项目成果

相关文献

中文摘要
翻译
在放疗和化疗等标准癌症治疗失败后，替代治疗对于治愈癌症至关重要。以增强免疫系统对抗癌症的能力为基础的癌症免疫疗法已经成为一种前景
英文摘要
Upon failure of standard cancer treatments such as radiotherapy and chemotherapy, alternative treatments are essential to cure cancer. Cancer immunotherapy, which is based on increasing the ability of the immune system to fight cancer, has become a promis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文